Cosmos Health expects to report preliminary second-quarter 2026 revenue of approximately $19.4 million, up about 31.5% from $14.75 million a year earlier. For the first half of 2026, revenue is projected at roughly $37.3 million, a 31% increase from $28.46 million in the prior-year period. Separately, the company has repurchased an additional 0.23 million shares at an average price of about $0.2539 per share, bringing total buybacks to 3.87 million shares for approximately $0.758 million under its $5 million share repurchase program, which runs through December 31, 2026.
Cosmos Health Inc.Preliminary Q2 revenue up 31.5% YoY and share buyback program progress